+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome



BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome



Genetics and Molecular Biology 39(2): 223-231



Approximately 5-10% of breast cancers are caused by germline mutations in high penetrance predisposition genes. Among these, BRCA1 and BRCA2, which are associated with the Hereditary Breast and Ovarian Cancer (HBOC) syndrome, are the most frequently affected genes. Recent studies confirm that gene rearrangements, especially in BRCA1, are responsible for a significant proportion of mutations in certain populations. In this study we determined the prevalence of BRCA rearrangements in 145 unrelated Brazilian individuals at risk for HBOC syndrome who had not been previously tested for BRCA mutations. Using Multiplex Ligation-dependent Probe Amplification (MLPA) and a specific PCR-based protocol to identify a Portuguese founder BRCA2 mutation, we identified two (1,4%) individuals with germline BRCA1 rearrangements (c.547+240_5193+178del and c.4675+467_5075-990del) and three probands with the c.156_157insAlu founder BRCA2 rearrangement. Furthermore, two families with false positive MLPA results were shown to carry a deleterious point mutation at the probe binding site. This study comprises the largest Brazilian series of HBOC families tested for BRCA1 and BRCA2 rearrangements to date and includes patients from three regions of the country. The overall observed rearrangement frequency of 3.44% indicates that rearrangements are relatively uncommon in the admixed population of Brazil.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057279481

Download citation: RISBibTeXText

PMID: 27303907

DOI: 10.1590/1678-4685-gmb-2014-0350


Related references

Identifying genomic rearrangements in BRCA1 and BRCA2 in high-risk individuals for hereditary breast and ovarian cancer. Journal of Clinical Oncology 29(27_Suppl): 163-163, 2016

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice 9: 12, 2011

Prevalence of the BRCA1 founder mutation c5266dup in Brazilian individuals at-risk for the Hereditary Breast and Ovarian Cancer Syndrome. 2012

Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families. Breast Cancer Research and Treatment 145(3): 625-634, 2014

Prevalence of BRCA1 and BRCA2 founder mutations in Brazilian hereditary breast and ovarian cancer families. Journal of Clinical Oncology 26(15_Suppl): 22108-22108, 2016

Hereditary Breast and Ovarian Cancer Syndrome: Moving Beyond BRCA1 and BRCA2. Advances in Anatomic Pathology 25(2): 85-95, 2018

Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosomes and Cancer 45(9): 791-797, 2006

Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome. American Journal of Medical Genetics. Part a 117a(3): 304-305, 2003

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome. Obstetrics and Gynecology Clinics of North America 37(1): 109-33 Table of Contents, 2010

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation. Journal of Obstetrics and Gynaecology Canada 29(1): 45-60, 2007

Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2. Cancer 120(10): 1557-1564, 2014

Recommended Extension of Indication Criteria for Genetic Testing of BRCA1 and BRCA2 Mutations in Hereditary Breast and Ovarian Cancer Syndrome. Klinicka Onkologie 29(Suppl. 1): S9, 2016

Hereditary breast and ovarian cancer syndrome A significant fraction of familial cases is not caused by mutations in BRCA1 or BRCA2 genes. American Journal of Human Genetics 59(4 Suppl. ): A35, 1996

Molecular-genetic analysis of BRCA1 and BRCA2 mutations in Bulgarian patients with hereditary breast ovarian cancer (HBOC) syndrome. European Journal of Cancer 61: S53-S54, 2016

High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. Bmc Medical Genetics 8: 32, 2007